Eleclazine hydrochloride
Eleclazine hydrochloride (GS 6615 hydrochloride) is a selective late sodium current inhibitor with an IC50 of 0.7 μM. It is a research tool used in cardiovascular studies, particularly for investigating arrhythmias and heart failure in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1448754-43-5
Product Name Alternative
Cardiac arrhythmias, atrial premature beats, KcsA, Inhibitor, inhibit, Na channels, Na+ channels, Na+ current, epinephrine, Eleclazine, Eleclazine Hydrochloride, Eleclazine hydrochloride, GS6615, GS-6615, GS6615 Hydrochloride, GS-6615 Hydrochloride, GS 6615, GS 6615 hydrochloride, GS 6615 Hydrochloride, hiPSC, SodiumChannel, Sodium Channel, porcine, Potassium Channel
Field of Research
Pharmacology & Drug Discovery
Purity
98.95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (8.85 mM) ; DMSO:100 mg/mL (221.32 mM)
Smiles
Cl.FC (F) (F) Oc1ccc (cc1) -c1ccc2OCCN (Cc3ncccn3) C (=O) c2c1
Molecular Formula
C21H17ClF3N3O3
Molecular Weight
451.83
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1392350-01 0.5 mg (E-Coli)
Recombinant Human C-type lectin domain family 5 member A (CLEC5A), partial
Sign In for Pricing
View Details 
MBS1392350-02 0.05 mg (Baculovirus)
Recombinant Human C-type lectin domain family 5 member A (CLEC5A), partial
Sign In for Pricing
View Details 
MBS1392350-03 0.5 mg (Yeast)
Recombinant Human C-type lectin domain family 5 member A (CLEC5A), partial
Sign In for Pricing
View Details MBS1392350-04 0.05 mg (Mammalian-Cell)
Recombinant Human C-type lectin domain family 5 member A (CLEC5A), partial
Sign In for Pricing
View Details MBS1392350-05 1 mg (E-Coli)
Recombinant Human C-type lectin domain family 5 member A (CLEC5A), partial
Sign In for Pricing
View Details MBS1392350-06 0.1 mg (Baculovirus)
Recombinant Human C-type lectin domain family 5 member A (CLEC5A), partial
Sign In for Pricing
View Details